BGPT: Author Review: Dante Rotili

Explore by Goal

Quick Explanation Copied

Dante Rotili — evidence-based scientific appraisal (from provided bibliometrics + paper metadata)

High scholarly visibility: 274 works, 8868 citations, h-index 52 (OpenAlex record provided by you).
Strong thematic center on epigenetics, especially sirtuins/HDACs and small-molecule modulation (supported by multiple highly cited works below).
Major limitation: your input does not include full-text results, experimental details, or methods for systematic critical assessment of rigor/reproducibility—only bibliographic/abstract-level metadata.

Long Explanation

Author Review: Dante Rotili

Date context: May 01, 2026 • Mode: skeptical, evidence-weighted • Data available: OpenAlex bibliometrics + selected DOI/abstract snippets provided

Publication volume over time (from provided OpenAlex counts_by_year)

Raw counts by year are plotted exactly as given in your input. This is bibliometric activity, not experimental quality.

Open-access share by year (from provided oa_works_count)

Computed as (oa_works_count / works_count) using only your provided numbers. No inference about causality.

Topic emphasis (from provided OpenAlex topic scores)

This is topic-modeling output from OpenAlex; it is not a direct measure of experimental depth or correctness.

Evidence-anchored scientific strengths (based on provided DOI-level metadata)

1) Clear focus on epigenetic enzymes and chemical biology (sirtuins/HDACs) with both mechanistic and chemistry-heavy contributions. The selected high-impact works you provided include (i) broad sirtuin/epigenetic review synthesis and (ii) structure/mechanism and small-molecule modulation themes.

Review synthesis on sirtuin functions and modulation, spanning chemistry-to-clinic framing:
Mechanistic/biophysical chemical-biology angle: structural basis of sirtuin 6 activation by synthetic small molecules:
Epigenetic targeting as anticancer concept work: histone deacetylation in epigenetics and its attractiveness for anticancer therapy (review):

What the provided works suggest (with explicit epistemic limits)

Your provided input includes abstracts/snippets for several top works, but not full methods, raw figures, or replication attempts. Therefore, I can evaluate only what is supported by the metadata/abstract text you supplied, not whether each claim generalizes across experiments.

Chemical biology competence (inference): multiple JMC/Angewandte-style topics appear in the top works list you supplied, including selective HDAC inhibition chemistry and sirtuin activation structure. However, without experimental details (assays, controls, selectivity panels), I cannot judge potency/selectivity reliability.
Mechanistic biological integration (inference): an example work ties ammonia-induced autophagy/mitophagy to SIRT5 regulation via urea cycle control (CPS1 mention in abstract). This suggests biological pathway linkage rather than only chemistry.
Epigenetic enzyme breadth across enzyme classes: the selected set includes both deacetylases (HDAC/sirtuin) and other chromatin-modifying enzymes (e.g., histone acetyltransferase inhibition) in your provided list.

Key uncertainty: Without full text, I cannot assess (a) assay system appropriateness to human biology, (b) off-target/selectivity panel breadth, (c) statistical rigor (n, blinding/randomization), or (d) whether findings were replicated by independent groups.

Selected top works (from your input) ranked by cited_by_count

This table uses only the top_works list that was included in your prompt.

Year	Title	Type	Journal	Cited by (OpenAlex snapshot)	DOI
2016	Sirtuin functions and modulation: from chemistry to the clinic	review	Clinical Epigenetics	377	10.1186/s13148-016-0224-3
2015	SIRT5 regulation of ammonia-induced autophagy and mitophagy	article	Autophagy	331	10.1080/15548627.2015.1009778
2005	Histone deacetylation in epigenetics: An attractive target for anticancer therapy	review	Medicinal Research Reviews	314	10.1002/med.20024
2017	Correction: Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma	erratum	Scientific Reports	288	10.1038/srep46645
2008	Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect	article	Oncogene	261	10.1038/onc.2008.436
2012	Inhibition of Class I Histone Deacetylases Unveils a Mitochondrial Signature and Enhances Oxidative Metabolism in Skeletal Muscle and Adipose Tissue	article	Diabetes	235	10.2337/db12-0548
2011	Targeting Histone Demethylases: A New Avenue for the Fight against Cancer	article	Genes & Cancer	190	10.1177/1947601911417976
2005	Class II (IIa)-Selective Histone Deacetylase Inhibitors. 1. Synthesis and Biological Evaluation of Novel (Aryloxopropenyl)pyrrolyl Hydroxyamides	article	Journal of Medicinal Chemistry	182	10.1021/jm049002a
2016	Structural Basis of Sirtuin 6 Activation by Synthetic Small Molecules	article	Angewandte Chemie International Edition	164	10.1002/anie.201610082
2006	Small-Molecule Inhibitors of Histone Acetyltransferase Activity: Identification and Biological Properties	article	Journal of Medicinal Chemistry	144	10.1021/jm060601m

Note: the table includes an erratum (correction) work with high “cited by” count in the OpenAlex snapshot; errata can be cited for bibliographic/record-correction reasons as well as scientific content.

Scientific quality critique (what can/can’t be concluded)

Known from your input: bibliometric indicators (works_count, cited_by_count, h-index) and thematic clustering (chemistry/biology/cancer/epigenetics-like topics) plus abstract-level descriptions for several top DOIs.

Not known from your input (critical gaps): assay details, statistical methods, sample sizes, blinding/randomization, independent replication, raw data availability, and full-spectrum selectivity/off-target assessments.

Reproducibility risk (unknown): Without full text, we cannot check whether claims depend on single-model evidence, whether dose-response curves are well-fitted, whether negative results are reported, or whether key experiments were repeated across labs.
Translational generalization risk (unknown): Epigenetic enzyme modulation often shows strong cell-line/pathway signals but variable in vivo outcomes; your provided snippets do not include species/model details beyond what abstract text names.
Citation-metric interpretability limits: High “cited by” can reflect broad relevance, but also can be inflated by review/field inertia or by citation of negative/controversial results. This must be separated from empirical robustness.
Publication-type mix: Several top items are reviews; reviews can be valuable but do not themselves demonstrate experimental rigor in the way primary studies do.

If you want a truly rigorous critique (BGPT “raw data” approach)

The most scientifically decisive step is to extract full-text experimental sections for a targeted subset (e.g., “sirtuin/HDAC small-molecule selectivity and mechanism papers”), then audit:

methods consistency across experiments
statistical reporting and controls
selectivity panels (cross-isoform/off-target)
raw image availability (if provided in full text)
attempts at replication or orthogonal readouts

Scientific conclusion with confidence

Conclusion: Based on the provided metadata/abstract snippets, Dante Rotili appears to be a consistently publishing, high-citation researcher centered on epigenetic targets (HDACs/sirtuins) and chemical biology, including mechanistic/structural and screening-to-function styles of work. However, the provided data do not include enough full-text experimental material to verify rigor, selectivity breadth, or reproducibility for specific claims.

Confidence: Moderate (for thematic/impact inference from bibliometrics and abstract-level statements), Low-to-Moderate (for any detailed claim about experimental rigor).

Feedback:

Updated: May 01, 2026

Key Insight

A coherent through-line appears: translating chromatin-enzyme chemistry (inhibitors/activators) into mechanistic claims (structure/pathway linkage) across diverse epigenetic targets—an approach that can be powerful but is especially vulnerable to selectivity and model-generalization issues unless rigorously audited.

Analysis Wizard

No bioinformatics code is justified from the provided bibliographic-only data; full-text extraction and figure parsing would be required to compute effect-size summaries.

Hypothesis Graveyard

“Any sirtuin modulator that binds will reproduce the same cellular phenotype” — likely false because substrate spectra, isoform distribution, and off-target epigenetic effects can alter downstream acetylation landscapes.

“HDAC inhibition effects are universally mediated by a single canonical pathway” — overly reductionist given that HDAC/epigenetic targets often couple to multiple stress and transcriptional programs across tissues/models.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I may overweight abstract-level statements because full text was not provided, which can inflate confidence in mechanistic interpretations.

Stay current without chasing every paper.

Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.

Check Claims Before You Publish

See how your reported results read as versioned evidence records — linked to experiments and limitations.Know what the science actually supports before you trust the answer.